A Biopharma Pivot with Compugen's Dr. Anat Cohen-Dayag

We love to hear from our listeners. Send us a message. Dr. Anat Cohen-Dayag transformed her company from a computational biology service provider to a clinical-stage biopharma with multiple cancer immunotherapy candidates, and she did it in a remarkably short period of time. Listen in as she discusses the human resources, financial, and capital strategies she deployed to build a biotech on the back of computational science, and shares her vision for the future of drug discovery. Access t...